Tp91. Tp091 Epidemiology and Translational Advances in Sars-Cov-2 2021
DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3782
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2 Infection and ENaC Activity Are Both Inhibited by Nafamostat Applied Apically on Human Airway Epithelial Cells in Air-Liquid Interface Culture

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles